Diagnosis and Management in Dementia 2020
DOI: 10.1016/b978-0-12-815854-8.00030-6
|View full text |Cite
|
Sign up to set email alerts
|

Choline-containing phospholipids and treatment of adult-onset dementia disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
8
0
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(10 citation statements)
references
References 31 publications
0
8
0
2
Order By: Relevance
“…Other choline-containing PLs include sphingomyelin (SM) which is abundant in the myelin sheath and maintains the integrity of the axonal covering [ 35 ]. SM is also reported to take part in cellular processes, signal transduction and the inflammatory cascade [ 36 ].…”
Section: Importance Of Choline-containing Phospholipids In Brainmentioning
confidence: 99%
See 2 more Smart Citations
“…Other choline-containing PLs include sphingomyelin (SM) which is abundant in the myelin sheath and maintains the integrity of the axonal covering [ 35 ]. SM is also reported to take part in cellular processes, signal transduction and the inflammatory cascade [ 36 ].…”
Section: Importance Of Choline-containing Phospholipids In Brainmentioning
confidence: 99%
“…A study conducted on rats fed with lecithin derived from soybeans or eggs found that forms of lecithin increased brain choline, blood choline and Ach synthesis in the brain [ 122 ]. Lecithin, alone and in combination, has been tested for the potential to regress the progression of dementia and AD in 21 studies and 12 randomized trials [ 35 ]. Clear evidence supporting its role in the amelioration of dementia and AD is not established.…”
Section: Choline-specific Therapeutic Strategies For the Amelioration Of Tbi And Coexisting Neurological Diseasesmentioning
confidence: 99%
See 1 more Smart Citation
“…The precursors are first used as a substrate for acetylcholine synthesis, which can improve cholinergic neurotransmission (Hurtado et al, 2011). ACh precursors have been shown to prolong the favorable effects of acetylcholinesterase inhibitors on cognitive and behavioral improvements in patients with Alzheimer's disease (AD) and mild to moderate vascular dementia Amenta et al, 2020). They may have significant neuroprotective benefits in addition to serving as precursors by maintaining and supplying the membrane structure of neurons (Rao et al, 2000).…”
mentioning
confidence: 99%
“…CCPLs and the acetylcholinesterase inhibitors were the treatments more largely studied in clinical trials for the AD consistent with the hypothesis that a replacement/enhancement of the cholinergic function may be useful in the treatment of AD patients. Based on the available results, it has been hypothesized that CCPLs could still have a place in the pharmacotherapy of adult-onset dementia disorders (Amenta et al, 2020).…”
mentioning
confidence: 99%